APHAIA

Owners

Goods & Services

Pharmaceutical research and development services; biochemical research and development services; medical research and development services; all of the foregoing excluding services in relation to any goods that consist of, contain or are derived from cannabis, marijuana or hemp

Pharmaceutical preparations for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the treatment of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for the prevention of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for improving mood and mental and physical wellbeing; food supplements and dietary preparations adapted for medical purposes for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietary preparations adapted for medical purposes for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietetic preparations adapted for medical purposes for the treatment of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for the prevention of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for improving mood and mental and physical well-being all of the foregoing excluding any goods that consist of, contain or are derived from cannabis, marijuana or hemp